3,4-Dihydro-2H-1-benzopyran-8-sulfonamide | 89836-55-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 3,4-Dihydro-2H-1-benzopyran-8-sulfonamide
• 英文别名: 3,4-dihydro-2H-chromene-8-sulfonamide
• CAS: 89836-55-5
• 化学式: C₉H₁₁NO₃S
• 分子量: 213.26
• InChiKey: HYRPZVIVHZSSND-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  77.8
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• [EN] NOVEL N-ACYL-ARYLSULFONAMIDE DERIVATIVES AS AMINOACYL-TRNA SYNTHETASE INHIBITORS<br/>[FR] NOUVEAUX DÉRIVÉS DE N-ACYL-ARYLSULFONAMIDE UTILISÉS EN TANT QU'INHIBITEURS D'AMINOACYL-ARNT SYNTHÉTASE
  申请人：LATVIAN INST ORGANIC SYNTHESIS

  公开号：WO2016129983A1

  公开（公告）日：2016-08-18

  The present invention relates to novel N-acyl-diarysulfonamides acting as inhibitors of bacterial aminoacyl-tRNA synthetase. These can be used as medicines or as constituent of medicines for the treatment of bacterial infections.

  本发明涉及作为细菌氨酰-tRNA合成酶抑制剂的新型N-酰基二芳基磺酰胺。这些可以用作药物或药物成分，用于治疗细菌感染。
• [EN] SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER<br/>[FR] ACYLSULFONAMIDES SUBSTITUÉS POUR LE TRAITEMENT DU CANCER
  申请人：BROAD INST INC

  公开号：WO2022081807A1

  公开（公告）日：2022-04-21

  The present invention provides acyl sulfonamide compounds of general formula (I): in which R1, R2, R3, R4, R5, R6· Raand Rbare as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients as well as methods of treatment and/or prophylaxis of diseases, particularly cancer, more particularly cancer in which KAT6A and/or KAT6B is focally amplified, said method comprising administering an effective amount of at least one compound of formula (I) to a subject in need thereof.

  本发明提供了通式（I）的酰基磺酰胺化合物：其中，R1、R2、R3、R4、R5、R6·Ra和Rb如本文所述和定义，以及制备该化合物的方法，用于制备该化合物的中间体化合物，包含该化合物的药物组合物和组合物，以及使用该化合物制造用于治疗或预防疾病的药物组合物，特别是治疗过度增生性疾病的药物组合物，作为唯一的活性成分或与其他活性成分组合使用，以及治疗和/或预防疾病的方法，特别是癌症，更特别是KAT6A和/或KAT6B局部扩增的癌症，其中该方法包括向需要该方法的受体中施用至少一种通式（I）的有效量化合物。
• N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors
  申请人：Oxford Drug Design Limited

  公开号：US11072581B2

  公开（公告）日：2021-07-27

  The present invention relates to novel N-acyl-diarysulfonamides acting as inhibitors of bacterial aminoacyl-tRNA synthetase. These can be used as medicines or as constituent of medicines for the treatment of bacterial infections.

  本发明涉及作为细菌氨基酰-tRNA 合成酶抑制剂的新型 N-酰基二亚磺酰胺类化合物。这些药物可用作治疗细菌感染的药物或药物成分。
• NOVEL N-ACYL-ARYLSULFONAMIDE DERIVATIVES AS AMINOACYL-TRNA SYNTHETASE INHIBITORS
  申请人：Oxford Drug Design Limited

  公开号：EP3259250A1

  公开（公告）日：2017-12-27